Daratumumab Monoclonal Antibody from Canada
Daratumumab human IgG1k monoclonal antibody targeting CD38 for multiple myeloma. Unmixed HTS 3002.13.0010 immunological biotech product.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• CD38 binding assays
• Hematology-specific FDA paths